In vitro inhibitory effect of two commercial probiotics on chromogenic actinomycetes

Gobbi, Emanuela; Francesco, Maria Antonia De; Piccinelli, Giorgio; Caruso, Arnaldo; Bardellini, Elena; Majorana, Alessandra

doi:10.1007/s40368-020-00512-2

Cited by 6 publications

(3 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The range of specific probiotic applications of BLIS M18 have largely been prompted by idiosyncrasies of its BLIS spectrum ( Supplementary Table B ). Successful outcomes have been reported not only for its impact on Cariogram index ( Di Pierro et al, 2015b ; Tandelilin et al, 2018 ; Poorni et al, 2022 ), reduction of gingivitis/periodontitis ( Scariya et al, 2015 ) and halitosis ( Benic et al, 2019 ; Yoo et al, 2020 ) and modulation of black staining plaque ( Gobbi et al, 2020 ), but also for its unanticipated postbiotic activity against colon cancer cells ( Karaçam and Tunçer, 2022 ) and the important Gram-negative pathogens P. aeruginosa and Klebsiella pneumoniae ( Tunçer and Karaçam, 2020 ).…”

Section: Blis-producing Streptococcus Salivarius A...mentioning

confidence: 99%

Beneficial modulation of human health in the oral cavity and beyond using bacteriocin-like inhibitory substance-producing streptococcal probiotics

Tagg¹,

Harold²,

Jain³

et al. 2023

Front. Microbiol.

View full text Add to dashboard Cite

The human oral cavity contains a diversity of microbial habitats that have been adopted and adapted to as homeland by an amazingly heterogeneous population of microorganisms collectively referred to as the oral microbiota. These microbes generally co-habit in harmonious homeostasis. However, under conditions of imposed stress, as with changes to the host’s physiology or nutritional status, or as a response to foreign microbial or antimicrobial incursions, some components of the oral “microbiome” (viz. the in situ microbiota) may enter a dysbiotic state. This microbiome dysbiosis can manifest in a variety of guises including streptococcal sore throats, dental caries, oral thrush, halitosis and periodontal disease. Most of the strategies currently available for the management or treatment of microbial diseases of the oral cavity focus on the repetitive “broad sweep” and short-term culling of oral microbe populations, hopefully including the perceived principal pathogens. Both physical and chemical techniques are used. However, the application of more focused approaches to the harnessing or elimination of key oral cavity pathogens is now feasible through the use of probiotic strains that are naturally adapted for oral cavity colonization and also are equipped to produce anti-competitor molecules such as the bacteriocins and bacteriocin-like inhibitory substances (viz BLIS). Some of these probiotics are capable of suppressing the proliferation of a variety of recognized microbial pathogens of the human mouth, thereby assisting with the restoration of oral microbiome homeostasis. BLIS K12 and BLIS M18, the progenitors of the BLIS-producing oral probiotics, are members of the human oral cavity commensal species Streptococcus salivarius. More recently however, a number of other streptococcal and some non-streptococcal candidate oral probiotics have also been promoted. What is becoming increasingly apparent is that the future for oral probiotic applications will probably extend well beyond the attempted limitation of the direct pathological consequences of oral microbiome dysbiosis to also encompass a plethora of systemic diseases and disorders of the human host. The background to and the evolving prospects for the beneficial modulation of the oral microbiome via the application of BLIS-producing S. salivarius probiotics comprises the principal focus of the present review.

show abstract

Section: Blis-producing Streptococcus Salivarius A...mentioning

confidence: 99%

Beneficial modulation of human health in the oral cavity and beyond using bacteriocin-like inhibitory substance-producing streptococcal probiotics

Tagg¹,

Harold²,

Jain³

et al. 2023

Front. Microbiol.

View full text Add to dashboard Cite

show abstract

“…В клинических исследованиях продемонстрирована эффективность и безопасность S. salivarius М18 в профилактике кариеса [94,[98][99][100][101], устранении галитоза [102], лечении пародонтита [103].…”

unclassified

Changes in the organs and tissues of the oral cavity in the new coronavirus infection (COVID-19): A review

2022

View full text Add to dashboard Cite

SARS-CoV-2 infection can cause changes in the organs and tissues of the oral cavity, which is associated with a wide distribution of angiotensin-converting enzyme type 2 in the oral cavity, mainly epithelial cells of the oral mucosa, gums and fibroblasts of the periodontal ligament. Thus, the oral mucosa is susceptible to SARS-CoV-2 infection and may act as a gateway for the virus, as well as a reservoir for SARS-CoV-2. We searched the literature for the period from the beginning of the pandemic until May 30, 2022, devoted to the study of changes in the organs and tissues of the oral cavity with a new coronavirus infection (COVID-19) in the electronic search engines PubMed/MEDLINE and Scopus. A special place in the study of changes in the organs and tissues of the oral cavity with a new coronavirus infection (COVID-19) is occupied by periodontal pathology. A number of reviews and clinical studies conclude the importance of good oral hygiene and periodontal health as an important aspect of COVID-19 prevention and management. Oral probiotics can be considered as a promising direction for correcting changes in organs and tissues of the oral cavity in COVID-19.

show abstract

“…Regarding the inhibitory potential of L. reuteri strains or strain mixtures on F. nucleatum, clearly pure L. reuteri ATCC PTA 5289 had the best anti-pathogen effect. By way of exception, A. actinomycetemcomitans was more reuterin-resistant and M18-susceptible, which had been reported before for culture supernatants of these probiotics [34]. Critically, with depletion of the essential glycerol the inhibition can turn into a growth spurt.…”

Section: Plos Onementioning

confidence: 62%

Untitled

View full text Add to dashboard Cite

In vitro inhibitory effect of two commercial probiotics on chromogenic actinomycetes

Cited by 6 publications

References 30 publications

Beneficial modulation of human health in the oral cavity and beyond using bacteriocin-like inhibitory substance-producing streptococcal probiotics

Beneficial modulation of human health in the oral cavity and beyond using bacteriocin-like inhibitory substance-producing streptococcal probiotics

Changes in the organs and tissues of the oral cavity in the new coronavirus infection (COVID-19): A review

Untitled

Contact Info

Product

Resources

About